The Lancet Regional Health – Europe publishes ‘real-world evidence’ from ALK-sponsored study confirming long-term benefits of allergy immunotherapy in allergic rhinitis and asthma

COPENHAGEN, Denmark, Dec. 1, 2021 /PRNewswire/ — ALK (ALKB: DC) (OMX: ALK B) (OMX: AKABY) (OMX: AKBLF) today announced that results from the REACT study, a large retrospective real-world study comprising more...

Leading Cancer Center in France, L’Institut de Cancérologie de l’Ouest (ICO), Joins the TriNetX Network to Strengthen Research Capabilities

St Herblain, France, September 27, 2021 â€” L’Institut de Cancérologie de l’Ouest (ICO), one of the leading provincial cancer centers in France, has joined the TriNetX global health research network to facilitate innovative patient...